TB-500 protocol considerations Reported dosing in the research literature: Starting dose: 500 mcg daily, subcutaneous injection Titration: Increase by 100 to 150 mcg every two weeks as tolerated Target dose: 750 to 1000 mcg daily by weeks five through twelve Weekly total: Approximately 5 mg per week at full dose Cycle length: Eight to twelve weeks, with optional extension to sixteen weeks TB-500 is typically administered once daily via subcutaneous injection, with consistent timing and systematic site rotation
Schedule a consultation today to learn whether GLP-1 treatment fits your goals and discover a supportive, personalized path forward
It may cost less if you learn how to self-administer the injections
In this study, the brand name was extracted from the discontinuation note and used to determine if the drug was an AOM or ADM
Since starting TRT, John has lost 11 percent of his body fat, hit new PRs, and can keep up with the weight, pace, and reps of high schoolers at his gym